NO20060475L - Rekombinant lubricinmolekyler og anvendelser derav - Google Patents

Rekombinant lubricinmolekyler og anvendelser derav

Info

Publication number
NO20060475L
NO20060475L NO20060475A NO20060475A NO20060475L NO 20060475 L NO20060475 L NO 20060475L NO 20060475 A NO20060475 A NO 20060475A NO 20060475 A NO20060475 A NO 20060475A NO 20060475 L NO20060475 L NO 20060475L
Authority
NO
Norway
Prior art keywords
applications
recombinant lubricin
lubricin molecules
molecules
recombinant
Prior art date
Application number
NO20060475A
Other languages
English (en)
Inventor
Lisa Anne Racie
Carl Ralph Flannery
Christopher John Corcoran
Bethany Annis Freeman
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20060475L publication Critical patent/NO20060475L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Rekombinant lubricinmolekyler og anvendelser derav. Nye rekombinante lubricinmolekyler og anvendelser derav som smøremidler, antiadhesive midler og eller intraartikulære supplementer for, f. eks., synovialledd, menisk, ledd, peritoneum, perikardium og pleura tilveiebringes.
NO20060475A 2003-08-14 2006-01-30 Rekombinant lubricinmolekyler og anvendelser derav NO20060475L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49574103P 2003-08-14 2003-08-14
PCT/US2004/026508 WO2005016130A2 (en) 2003-08-14 2004-08-13 Recombinant lubricin molecules and uses thereof

Publications (1)

Publication Number Publication Date
NO20060475L true NO20060475L (no) 2006-03-13

Family

ID=34193342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060475A NO20060475L (no) 2003-08-14 2006-01-30 Rekombinant lubricinmolekyler og anvendelser derav

Country Status (21)

Country Link
US (6) US7642236B2 (no)
EP (1) EP1663291B1 (no)
JP (1) JP2007502122A (no)
KR (1) KR101078202B1 (no)
CN (2) CN102924584A (no)
AU (2) AU2004264970B2 (no)
BR (1) BRPI0413553A (no)
CR (1) CR8204A (no)
DK (1) DK1663291T3 (no)
EC (1) ECSP066364A (no)
ES (1) ES2388970T3 (no)
HK (1) HK1089110A1 (no)
IL (2) IL173258A (no)
MX (1) MXPA06001658A (no)
NO (1) NO20060475L (no)
NZ (1) NZ545021A (no)
RU (2) RU2376313C2 (no)
SG (1) SG145724A1 (no)
UA (1) UA91818C2 (no)
WO (1) WO2005016130A2 (no)
ZA (1) ZA200601291B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US20080287369A1 (en) * 2004-07-23 2008-11-20 Jay Gregory D Compositions and Methods for Viscosupplementation
US20090068247A1 (en) * 2007-09-12 2009-03-12 Mucosal Therapeutics Biocompatible devices coated with a tribonectin and methods for their production
US20090104148A1 (en) * 2007-09-18 2009-04-23 Jay Gregory D Treatment and prevention of joint disease
US8506944B2 (en) * 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
JP5508398B2 (ja) * 2008-05-07 2014-05-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 眼の表面潤滑の治療的補充及び強化
WO2010083239A2 (en) * 2009-01-13 2010-07-22 Truitt Edward R Iii Therapeutic modulation of vaginal epithelium boundary lubrication
CA2762989C (en) * 2009-05-22 2021-04-13 Benjamin Sullivan Prg4 for treatment of oral cavity boundary lubrication disorders
ES2627103T3 (es) * 2010-01-19 2017-07-26 Lubris Llc Composiciones de cuidado bucal y métodos
US8716204B2 (en) 2010-07-27 2014-05-06 Zimmer, Inc. Synthetic synovial fluid compositions and methods for making the same
US20130116186A1 (en) * 2011-10-04 2013-05-09 Rhode Island Hospital, A Lifespan Partner Lubricin injections to maintain cartilage health
EP2948553B1 (en) * 2013-01-25 2020-04-01 Baylor College Of Medicine A helper-dependent adenoviral gene therapy delivery and expression system
US20150010606A1 (en) * 2013-07-08 2015-01-08 Arthrex, Inc. Intra-articular injection and implant attachment of molecule consisting of lubricin and extracellular superoxide dismutase or hyaluronic acid and extracellular superoxide dismutase
EP3057451A4 (en) * 2013-10-16 2017-06-21 Ensisheim Partners LLC Protein-specific formulations
WO2015060935A1 (en) * 2013-10-22 2015-04-30 Lubris, Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
EP4062924A1 (en) 2013-11-26 2022-09-28 Lubris LLC Compositions and methods for inhibiting intercellular interactions
ES2808199T3 (es) 2015-01-26 2021-02-25 Lubris Llc Uso de PRG4 como un agente antiinflamatorio
EP3769788A1 (en) 2016-01-13 2021-01-27 Genzyme Corporation Recombinant aav vectors expressing osteoprotective genes, including has2 and lubricin, useful in the treatment of osteoarthritis and related joint conditions in mammals
EP3408397B1 (en) 2016-01-27 2020-07-15 Just-Evotec Biologics, Inc. Hybrid promoter and uses thereof
JP2021527645A (ja) * 2018-06-21 2021-10-14 ルブリス，エルエルシー． 創傷治癒での使用のためのラブリシン
WO2020150390A1 (en) * 2019-01-15 2020-07-23 Cornell University Recombinant mucins, and compositions and methods for using the same
JP2023515504A (ja) * 2020-02-24 2023-04-13 ノバルティス アーゲー 組み換え産生されたポリペプチドの精製
IT202000022636A1 (it) 2020-09-25 2022-03-25 Ente Ospedaliero Specializzato In Gastroenterologia Istituto Nazionale Di Ricovero E Cura A Caratter “terapia di combinazione di sorafenib e/o regorafenib con la proteina ricombinante umana proteoglicano-4 per il trattamento dell'epatocarcinoma”

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734862A (en) 1956-02-14 Synthetic casein fiber elastic grease
US2487377A (en) 1948-04-17 1949-11-08 Socony Vacuum Oil Co Inc Lubricant
US2878184A (en) 1953-12-29 1959-03-17 Rockwell Mfg Co Hydrocarbon resistant glycerol base lubricant
AR207237A1 (es) 1974-02-25 1976-09-22 Thomas A Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes
US4438100A (en) 1980-04-25 1984-03-20 A/S Orthana Kemisk Fabrik Sterilized preserved, stable mucine-containing solutions
US5403592A (en) 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
GB8803697D0 (en) 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5260417A (en) 1989-04-03 1993-11-09 Genetics Institute, Inc. Megakaryocyte growth promoting activity protein
US5326558A (en) 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
US6433142B1 (en) * 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
AU652022B2 (en) 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
CN1107891A (zh) 1994-03-04 1995-09-06 上海贝特生物技术有限公司 人促巨核细胞生成素及其分离纯化和基因克隆方法及应用
US5515590A (en) 1994-07-19 1996-05-14 University Of Kentucky Research Foundation Method for reducing the generation of wear particulates from an implant
US5709020A (en) 1994-07-19 1998-01-20 University Of Kentucky Research Foundation Method for reducing the generation of wear particulates from an implant
US5510122A (en) 1994-09-28 1996-04-23 The Research Foundation Of State University Of New York Preparation and use of whole saliva
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US6960562B2 (en) 1999-04-23 2005-11-01 Rhode Island Hospital, A Lifespan Partner Tribonectin polypeptides and uses thereof
US7001881B1 (en) 1999-04-23 2006-02-21 Rhode Island Hospital Tribonectins
WO2001007068A1 (en) 1999-07-23 2001-02-01 Case Western Reserve University Novel methods and reagents for the treatment of osteoarthritis
EP1347993A2 (en) 2000-12-29 2003-10-01 Glaxo Group Limited Superficial zone protein and methods of making and using same
EP1440981A3 (en) 2003-01-21 2005-11-23 Research Association for Biotechnology Full-length human cdna

Also Published As

Publication number Publication date
JP2007502122A (ja) 2007-02-08
DK1663291T3 (da) 2012-07-02
US7642236B2 (en) 2010-01-05
EP1663291A2 (en) 2006-06-07
IL173258A0 (en) 2006-06-11
CR8204A (es) 2007-10-01
BRPI0413553A (pt) 2006-10-17
UA91818C2 (ru) 2010-09-10
US20100080848A1 (en) 2010-04-01
US20130196930A1 (en) 2013-08-01
MXPA06001658A (es) 2006-04-28
US20110189731A1 (en) 2011-08-04
WO2005016130A3 (en) 2006-02-02
AU2010201537A1 (en) 2010-05-06
AU2004264970A1 (en) 2005-02-24
US20070191268A1 (en) 2007-08-16
AU2004264970B2 (en) 2010-02-11
US8420793B2 (en) 2013-04-16
HK1089110A1 (en) 2006-11-24
IL173258A (en) 2010-12-30
KR20060072124A (ko) 2006-06-27
RU2009130434A (ru) 2011-02-20
CN102924584A (zh) 2013-02-13
US8987205B2 (en) 2015-03-24
ZA200601291B (en) 2010-08-25
AU2010201537B2 (en) 2012-02-23
ECSP066364A (es) 2006-08-30
NZ545021A (en) 2009-03-31
WO2005016130A2 (en) 2005-02-24
US7897571B2 (en) 2011-03-01
US7893029B2 (en) 2011-02-22
EP1663291A4 (en) 2009-08-05
ES2388970T3 (es) 2012-10-22
RU2376313C2 (ru) 2009-12-20
US20100074935A1 (en) 2010-03-25
RU2006107925A (ru) 2006-07-27
IL199528A (en) 2013-03-24
SG145724A1 (en) 2008-09-29
KR101078202B1 (ko) 2011-11-01
CN1867350A (zh) 2006-11-22
IL199528A0 (en) 2011-08-01
US20150343019A1 (en) 2015-12-03
EP1663291B1 (en) 2012-06-06

Similar Documents

Publication Publication Date Title
NO20060475L (no) Rekombinant lubricinmolekyler og anvendelser derav
NO20050380L (no) System og fremgangsmate for a anvende nanoskala fyllmateriale i nedhulls applikasjoner
GB2447383A (en) All electric subsea boosting system
NO20063029L (no) Fremgangsmate for skumming av en hydrokarbonborevaeske og for produksjon av lette hydrokarbonfluider
AR059667A1 (es) Montaje de desgaste
NO20073293L (no) Toll-liknende reseptor-3-antagonister, fremgangsmater og anvendelser
NO20075200L (no) Fremstilling av karotenoider i oljeaktige gjaer og fungi
NO20080246L (no) Anti-IGF1R-antistofformuleringer
CR20110245A (es) Mutantes fgf21 y uso de los mismos.
AR062069A1 (es) Replegado de proteinas recombinantes
NO20073135L (no) Nedihulls-verktoy betjent av lineaer induksjonsmotor
ATE485802T1 (de) Multidosis-phiolenanordnungen und adapter dafür
BR0116904A (pt) Composição e método para inibição da formação de hidratos de gases
BRPI0600504A (pt) conjunto de válvula para uma bomba usada para bombear fluido abrasivo
AR067033A1 (es) Recuperacion de hidrocarburos y de combustibles fosiles basada microondas
BRPI0617788A2 (pt) processos isolados estaticamente verificáveis com comunicação interprocessos
BR112015004024A2 (pt) composição de vedação com base em resina, e, método para formar uma vedação em uma formação subterrânea
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
BR112014016815A8 (pt) conjunto de ventilação de fabricação de compósito e modo de conexão
ATE501234T1 (de) Pyrolysesystem
DE502007001244D1 (de) Kosmetikeinheit mit zwei gekoppelten Teileinheiten
AR061212A1 (es) Un sistema adhesivo
BR0205420B1 (pt) processo e aparelho para lubrificar compressor tipo pistão.
UY25357A1 (es) Nuevos pentasacáridos, procedimiento para su preparación y composiciones farmacéuticas que los contienen.
ATE522964T1 (de) Vorrichtung zur verbindung von zwei schienensystemen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application